
    
      -  For each of isoniazid, ofloxacin, moxifloxacin, amikacin, and kanamycin: sensitivity and
           specificity of the investigational Xpert test for detection of drug resistance, using
           phenotypic drug susceptibility testing as the reference comparator

        -  For each of isoniazid, ofloxacin, moxifloxacin, amikacin, and kanamycin: sensitivity and
           specificity of the investigational Xpert test for detection of drug resistance, using
           mycobacterial DNA sequencing as the reference comparator

        -  Sensitivity and specificity, for detection of M. tuberculosis in sputum, of the
           investigational Xpert test and of the conventional Xpert MTB/RIF test, using culture as
           the reference comparator

        -  Diagnostic yield (for tuberculosis) of the investigational Xpert test and of the
           conventional Xpert MTB/RIF test

        -  For the investigational Xpert test, the proportion of specimens with a result of
           'invalid' and the proportion of specimens with a result of 'error'

        -  Proportion of study participants with M. tuberculosis detected in sputum

        -  Proportion of participants with drug resistant tuberculosis, by drug resistance pattern
           and by tuberculosis categorization (new case or not new case)
    
  